Joslin Diabetes Center, Harvard Medical School — Boston, Massachusetts

Joslin Diabetes Center, Harvard Medical School is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Joslin Diabetes Center, Harvard Medical School has participated in 2 clinical trials.

Therapeutic areas: Type 1 Diabetes Mellitus, Recent Onset type1 Diabetes.

Sponsors: Avotres Inc., Dompé Farmaceutici S.p.A.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Joslin Diabetes Center, Harvard Medical School?

Joslin Diabetes Center, Harvard Medical School has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Joslin Diabetes Center, Harvard Medical School conducted?

Joslin Diabetes Center, Harvard Medical School has 2 clinical trials on record. Their work covers Type 1 Diabetes Mellitus, Recent Onset type1 Diabetes.

Is Joslin Diabetes Center, Harvard Medical School accredited by Crixeo Health?

Joslin Diabetes Center, Harvard Medical School has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Joslin Diabetes Center, Harvard Medical School?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.